TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Franklin Resources BEN Q1 2026 Earnings Strong EPS Surprise of 2774 Amid Revenue Discretion Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations TATT Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Drops Over 5 LMB Q1 2026 Earnings Staggering EPS Surprise of Over 1000 Masks a 224 Stock Decline Americold Realty Trust COLD Holds Near Support as Modest Gains Signal Stability Bloom Energy BE Faces Selling Pressure as Stock Retreats from Resistance Zone NioCorp Developments Ltd Warrant NIOBW Surges 117 Testing Key Resistance at 201 Allarity Therapeutics ALLR Surges 66 as Volume Picks Up Testing Key Resistance BGC Q1 2026 Earnings Slight EPS Miss Triggers Modest SellOff Cheche Group CCG Q4 2024 Earnings EPS Beats Estimates by 4012 Revenue Not Reported Angel Studios Inc ANGX Q1 2026 Earnings Narrowing Losses Surprisedriven Stock Rally DTE Q1 2026 Earnings EPS Misses Estimates Amid Regulatory and Operational Headwinds OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue YETI Q1 2026 Earnings Strong Profit Beat Drives Shares Higher STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances